Unlocking AG-881: A New Era in Glioma Treatment (INDIGO Trial) Brain 12 Mins Read1 Vorasidenib (AG-881) is a promising targeted therapy for gliomas with IDH1 or IDH2 mutations. This novel approach could potentially revolutionize…
